EMBL-EBI Breaking News Axovia Therapeutics, Viralgen Partner on Bardet-Biedl Syndrome Gene Therapy Illinois Legislature Passes Cancer Patient Bill of Rights Galapagos Inks Deal With Catalent to Use New Jersey Site for Decentralized Cell Therapy Trials J&J Reports Strong Uptake of Carvykti and Rybrevant in Q4 Intellia Therapeutics Doses First Patient in Phase III Hereditary Angioedema Trial of CRISPR Drug NICE Recommends NHS England Provide AstraZeneca's Tagrisso for Adjuvant EGFR-Mutated NSCLC
